Total Payments
$10,643
2024 Payments
$752.23
Companies
42
Transactions
742
Medicare Patients
2,768
Medicare Billing
$176,216
Payment Breakdown by Category
Food & Beverage$10,323 (97.0%)
Education$319.89 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,323 | 717 | 97.0% |
| Education | $319.89 | 25 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,819 | 132 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,531 | 91 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,263 | 101 | $0 (2024) |
| PFIZER INC. | $734.56 | 68 | $0 (2021) |
| Lilly USA, LLC | $648.05 | 43 | $0 (2024) |
| Astellas Pharma US Inc | $558.43 | 23 | $0 (2024) |
| Allergan, Inc. | $550.23 | 67 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $533.23 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $329.03 | 22 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $273.50 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $752.23 | 41 | Novo Nordisk Inc ($156.03) |
| 2023 | $1,015 | 54 | AstraZeneca Pharmaceuticals LP ($215.29) |
| 2022 | $1,409 | 97 | Novo Nordisk Inc ($294.74) |
| 2021 | $1,263 | 73 | Novo Nordisk Inc ($340.03) |
| 2020 | $1,355 | 95 | GlaxoSmithKline, LLC. ($279.01) |
| 2019 | $1,724 | 132 | Novo Nordisk Inc ($303.63) |
| 2018 | $1,315 | 107 | PFIZER INC. ($343.94) |
| 2017 | $1,810 | 143 | Novo Nordisk Inc ($295.22) |
All Payment Transactions
742 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Obesity | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Cardio-renal | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Cardio-renal | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: ADHD | ||||||
| 06/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: UROLOGY | ||||||
| 06/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardio-renal | ||||||
| 05/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 496 | 983 | $82,960 | $35,200 |
| 2022 | 19 | 665 | 1,153 | $101,585 | $42,651 |
| 2021 | 22 | 807 | 1,480 | $107,981 | $51,383 |
| 2020 | 16 | 800 | 1,370 | $110,032 | $46,982 |
Total Patients
2,768
Total Services
4,986
Medicare Billing
$176,216
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 247 | $30,875 | $15,148 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $13,800 | $6,006 | 43.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 19 | $5,700 | $4,170 | 73.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 22 | 26 | $7,800 | $2,459 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 20 | $3,500 | $1,267 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 148 | $1,480 | $1,243 | 84.0% |
| 92548 | Test for balance and posture | Office | 2023 | 26 | 28 | $2,800 | $990.99 | 35.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 25 | $1,875 | $735.46 | 39.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $880.00 | $688.16 | 78.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 70 | $3,500 | $681.94 | 19.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 22 | 22 | $1,100 | $450.12 | 40.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 47 | $2,350 | $388.57 | 16.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 18 | 18 | $1,620 | $311.50 | 19.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 16 | 16 | $800.00 | $282.10 | 35.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 19 | 50 | $500.00 | $170.50 | 34.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 13 | 19 | $380.00 | $154.22 | 40.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 21 | 129 | $3,225 | $49.82 | 1.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 31 | $775.00 | $2.40 | 0.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 247 | $29,775 | $14,340 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $20,700 | $9,277 | 44.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 15 | $4,500 | $3,286 | 73.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 39 | $6,775 | $3,211 | 47.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 26 | 31 | $9,300 | $2,948 | 31.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,200 | $1,870 | 85.0% |
| 92548 | Test for balance and posture | Office | 2022 | 37 | 37 | $3,700 | $1,405 | 38.0% |
About Dr. Raul Rivera, MD
Dr. Raul Rivera, MD is a Internal Medicine healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205853843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raul Rivera, MD has received a total of $10,643 in payments from pharmaceutical and medical device companies, with $752.23 received in 2024. These payments were reported across 742 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($10,323).
As a Medicare-enrolled provider, Rivera has provided services to 2,768 Medicare beneficiaries, totaling 4,986 services with total Medicare billing of $176,216. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pasadena, TX
- Active Since 07/17/2006
- Last Updated 08/15/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205853843
Products in Payments
- Ozempic (Drug) $964.11
- FARXIGA (Drug) $867.63
- TRELEGY ELLIPTA (Drug) $624.58
- Kerendia (Drug) $533.23
- Victoza (Drug) $364.13
- SYMBICORT (Drug) $353.54
- ENTRESTO (Drug) $325.00
- UBRELVY (Drug) $247.16
- Vascepa (Drug) $225.89
- MYRBETRIQ (Drug) $223.04
- BREO (Drug) $213.19
- Rybelsus (Drug) $208.67
- RYBELSUS (Drug) $202.19
- ANORO (Drug) $196.53
- JARDIANCE (Drug) $191.49
- TRULICITY (Drug) $183.42
- VIAGRA (Drug) $174.86
- V-GO (Device) $172.98
- LINZESS (Drug) $171.61
- EUCRISA (Drug) $167.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882